By expenditures
| Name | Title | Type |
|---|---|---|
| Tina Sargent | Comptroller | Auditee |
| Julio Guridy | Executive Director | Auditee |
| Aida Nu?ez | INTERIM EXECUTIVE DIRECTOR | Auditee |
| Daniel Sefick | Principal | Auditee |
| Mandy Merchant | Principal | Auditee |
| Rich Larsen | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 346230 | 2024 | 2025-03-14 | Novogradac & Company LLP | $29.74M |
| 299848 | 2023 | 2024-03-28 | Cliftonlarsonallen LLP | $23.90M |
| 19402 | 2022 | 2023-03-30 | Cliftonlarsonallen LLP | $20.51M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 346230 | 2024 | 2025-03-14 | 1104622 | 2024-002 | Significant Deficiency | Yes | E |
| 346230 | 2024 | 2025-03-14 | 528180 | 2024-002 | Significant Deficiency | Yes | E |
| 299848 | 2023 | 2024-03-28 | 964233 | 2023-003 | Material Weakness | Yes | EN |
| 299848 | 2023 | 2024-03-28 | 964232 | 2023-003 | Material Weakness | Yes | EN |
| 299848 | 2023 | 2024-03-28 | 964231 | 2023-002 | Significant Deficiency | - | N |
| 299848 | 2023 | 2024-03-28 | 964230 | 2023-002 | Significant Deficiency | - | N |
| 299848 | 2023 | 2024-03-28 | 964229 | 2023-001 | Significant Deficiency | - | N |
| 299848 | 2023 | 2024-03-28 | 964228 | 2023-001 | Significant Deficiency | - | N |
| 299848 | 2023 | 2024-03-28 | 387791 | 2023-003 | Material Weakness | Yes | EN |
| 299848 | 2023 | 2024-03-28 | 387790 | 2023-003 | Material Weakness | Yes | EN |
| 299848 | 2023 | 2024-03-28 | 387789 | 2023-002 | Significant Deficiency | - | N |
| 299848 | 2023 | 2024-03-28 | 387788 | 2023-002 | Significant Deficiency | - | N |
| 299848 | 2023 | 2024-03-28 | 387787 | 2023-001 | Significant Deficiency | - | N |
| 299848 | 2023 | 2024-03-28 | 387786 | 2023-001 | Significant Deficiency | - | N |
| 19402 | 2022 | 2023-03-30 | 597815 | 2022-003 | Significant Deficiency | - | N |
| 19402 | 2022 | 2023-03-30 | 597814 | 2022-002 | Significant Deficiency | - | N |
| 19402 | 2022 | 2023-03-30 | 597813 | 2022-001 | Material Weakness | - | N |
| 19402 | 2022 | 2023-03-30 | 597812 | 2022-003 | Significant Deficiency | - | N |
| 19402 | 2022 | 2023-03-30 | 597811 | 2022-002 | Significant Deficiency | - | N |
| 19402 | 2022 | 2023-03-30 | 597810 | 2022-001 | Material Weakness | - | N |
| 19402 | 2022 | 2023-03-30 | 21373 | 2022-003 | Significant Deficiency | - | N |
| 19402 | 2022 | 2023-03-30 | 21372 | 2022-002 | Significant Deficiency | - | N |
| 19402 | 2022 | 2023-03-30 | 21371 | 2022-001 | Material Weakness | - | N |
| 19402 | 2022 | 2023-03-30 | 21370 | 2022-003 | Significant Deficiency | - | N |
| 19402 | 2022 | 2023-03-30 | 21369 | 2022-002 | Significant Deficiency | - | N |
| 19402 | 2022 | 2023-03-30 | 21368 | 2022-001 | Material Weakness | - | N |